Eagle Bay Advisors LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eagle Bay Advisors LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$68,976
+30.9%
770
+24.4%
0.03%
+6.7%
Q2 2023$52,702
-6.1%
619
-8.7%
0.03%
-3.2%
Q1 2023$56,105
-9.9%
678
-14.4%
0.03%
-11.4%
Q4 2022$62,291
+29.8%
792
+23.6%
0.04%
+16.7%
Q3 2022$48,000
-99.9%
641
-1.8%
0.03%
+15.4%
Q2 2022$42,563,000
+265918.8%
653
+155.1%
0.03%
+100.0%
Q1 2022$16,000
-11.1%
256
-20.5%
0.01%
+18.2%
Q4 2021$18,000
+5.9%
322
+29.8%
0.01%
+10.0%
Q3 2021$17,000
-5.6%
248
+0.8%
0.01%
-28.6%
Q2 2021$18,0002460.01%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders